Bone marrow transplantation · 2002
Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taketani T, Kikuchi A, Inatomi J, Hanada R, Kawaguchi H, Ida K, Oh-Ishi T, Arai T, Kishimoto H, Yamamoto K
Аннотация
We report a pediatric case of CAEBV and T cell-based Hodgkin's-like disease successfully treated with allo PBSCT from an HLA-matched sibling. The diagnosis of CAEBV was made from clinical signs and the presence of the EBV genome in PBMC and tumor cells. Conditioning with busulfan (BU) + etoposide (VP16) + cyclophosphamide (CY) was effective and well tolerated. EBV was totally eradicated by 3 months after allo PBSCT. Although she suffered from chronic GVHD of the liver, she has been well and free of disease for 47 months since PBSCT. We suggest allo PBSCT for CAEBV as a potent therapeutic strategy for eradication of the EBV genome and allowing immunological reconstitution.
Предметные рубрики MeSH
Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBusulfanChildChronic DiseaseCombined Modality TherapyCyclophosphamideEpstein-Barr Virus InfectionsEtoposideFemaleHerpesvirus 4, HumanHumansImmunosuppressive AgentsIn Situ HybridizationLymphomaStem Cell TransplantationTransplantation ConditioningTransplantation, Homologous